Table 1.
Clinical features of SCC patients with low or high DLX3 expression
| DLX3 | ||||||
|---|---|---|---|---|---|---|
| Low | High | |||||
| (n=33) | (n=88) | |||||
| Variables | P | |||||
| Age (years; mean ± SE) | 78.3 ± 1.9 | 77.7 ± 1 | > 0.99 | |||
| Sex | Male (%) | 57.60 | (19/33) | 63.60 | (56/88) | 0.4686 |
| Female (%) | 42.40 | (14/33) | 36.40 | (32/88) | ||
| Part | Face (%) | 69.70 | (23/33) | 63.60 | (56/88) | |
| Trunk (%) | 9.10 | (3/33) | 3.40 | (3/88) | ||
| Upper (%) | 6.10 | (2/33) | 17.10 | (15/88) | 0.0249 | |
| Lower (%) | 15.10 | (5/33) | 15.90 | (14/88) | ||
| Grade | G1 (%) | 54.50 | (18/33) | 65.90 | (58/88) | |
| G2 (%) | 27.30 | (9/33) | 30.70 | (27/88) | ||
| G3 (%) | 18.20 | (6/33) | 3.40 | (3/88) | 0.0008 | |
| Stage | I (%) | 36.30 | (12/33) | 38.60 | (34/88) | > 0.99 |
| II (%) | 39.40 | (13/33) | 48.90 | (43/88) | ||
| III (%) | 15.10 | (5/33) | 8.00 | (7/88) | ||
| IV (%) | 9.10 | (3/33) | 4.50 | (4/88) | ||
P values were obtained by the Fisher exact test.